Related Experiment Video
Updated: Jan 10, 2026
10:45
Stable Aqueous Suspensions of Manganese Ferrite Clusters with Tunable Nanoscale Dimension and Composition
Published on: February 5, 2022
4.6K
Glycine passivated Fe3O4 nanoparticles for thermal therapy
1Chemistry Division, Bhabha Atomic Research Centre, Mumbai, India.
Journal of Colloid and Interface Science
|January 3, 2012
Summary
Researchers developed glycine-passivated iron oxide nanoparticles (GMNPs) for cancer therapy. These biocompatible GMNPs exhibit excellent self-heating properties for hyperthermia treatment.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Iron oxide nanoparticles (Fe3O4) are promising for biomedical applications.
- Surface functionalization is crucial for nanoparticle stability and biocompatibility.
- Developing efficient heating agents for hyperthermia is an ongoing challenge.
Purpose of the Study:
- To synthesize glycine-passivated Fe3O4 magnetic nanoparticles (GMNPs) using a facile method.
- To characterize the synthesized GMNPs for their physical and chemical properties.
- To evaluate the potential of GMNPs as heating agents for cancer hyperthermia.
Main Methods:
- Facile soft chemical synthesis of Fe3O4 nanoparticles.
- Surface passivation with glycine (amino acid).
- Characterization using infrared spectroscopy, thermal analysis, elemental analysis, and light scattering.
Main Results:
- Successful synthesis of glycine-passivated Fe3O4 magnetic nanoparticles (GMNPs).
- Demonstrated enhanced colloidal stability, good magnetization, and excellent self-heating capacity.
- Confirmed cytocompatibility and accessible amine functional groups for bioconjugation.
- Achieved excellent specific absorption rate (SAR) for hyperthermia applications.
Conclusions:
- Glycine passivation provides stable, biocompatible Fe3O4 nanoparticles.
- GMNPs are effective heating agents for hyperthermia cancer treatment.
- The accessible functional groups allow for further biomolecule conjugation.
